Disadvantage in life sciences / biotech without STEM background?

Hey guys,

Title says all. I'm currently looking to transition from a megafund to a role at a much smaller but decent fund covering life sciences. I'm super lucky to be in a late stage process right now, especially because I have no bioscience/healthcare exposure in my past deals (all very traditional and boring). I also didn't study STEM in college at all (I majored in philosophy). 

The role I am looking at covers life sciences excluding pharma, with a focus on biotech and agtech.

While I am super interested in this industry (hence why I was able to recruit successfully), I am a little wary of my long-term prospects in the sector, especially since my background doesn't scream STEM. If I go down this route, my endgame is to end up in either VC covering the same sector, or to start/join a startup of my own within the sector. How much will my background hold me back? 

If the resounding answer is, "bad news - yes you will have a glass ceiling / be handicapped by your lack of STEM background and thus will be systemically disadvantaged forever", then there are other sectors I'm interested in which maybe I should go into instead.

While I have been taking some bio/chem MOOCs online, trying to read journals etc, I realize there is only so much I can do to further my understanding and credibility in the space compared to the plethora of PhDs and MDs. Even for those who didn't do grad school, it seems everyone else on my team has majored in biology/chemistry at the minimum.

What is the community's take? In particular if anyone is in this field I'd really appreciate some of your thoughts. 

Alternatively, anyone know if maybe there's a 2-year science degree I can do to quickly rebrand? 

Career Advancement Opportunities

April 2024 Private Equity

  • The Riverside Company 99.5%
  • Blackstone Group 99.0%
  • Warburg Pincus 98.4%
  • KKR (Kohlberg Kravis Roberts) 97.9%
  • Bain Capital 97.4%

Overall Employee Satisfaction

April 2024 Private Equity

  • The Riverside Company 99.5%
  • Blackstone Group 98.9%
  • KKR (Kohlberg Kravis Roberts) 98.4%
  • Ardian 97.9%
  • Bain Capital 97.4%

Professional Growth Opportunities

April 2024 Private Equity

  • The Riverside Company 99.5%
  • Bain Capital 99.0%
  • Blackstone Group 98.4%
  • Warburg Pincus 97.9%
  • Starwood Capital Group 97.4%

Total Avg Compensation

April 2024 Private Equity

  • Principal (9) $653
  • Director/MD (22) $569
  • Vice President (92) $362
  • 3rd+ Year Associate (90) $280
  • 2nd Year Associate (205) $268
  • 1st Year Associate (387) $229
  • 3rd+ Year Analyst (29) $154
  • 2nd Year Analyst (83) $134
  • 1st Year Analyst (246) $122
  • Intern/Summer Associate (32) $82
  • Intern/Summer Analyst (314) $59
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Betsy Massar's picture
Betsy Massar
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
Secyh62's picture
Secyh62
99.0
5
dosk17's picture
dosk17
98.9
6
GameTheory's picture
GameTheory
98.9
7
CompBanker's picture
CompBanker
98.9
8
kanon's picture
kanon
98.9
9
bolo up's picture
bolo up
98.8
10
Jamoldo's picture
Jamoldo
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”